Activity of the human (h) cystic fibrosis transmembrane conductance regulator (CFTR) channel is predominantly regulated by PKA-mediated phosphorylation. In contrast, Xenopus (X)CFTR is more responsive to PKC than PKA stimulation. We investigated the interaction between the two kinases in XCFTR. We expressed XCFTR in Xenopus oocytes and maximally stimulated it with PKA agonists. The magnitude of activation after PKC stimulation was about eightfold that without pretreatment with PKC agonist. hCFTR, expressed in the same system, lacked this response. We name this phenomenon XCFTR-specific PKC potentiation effect. To ascertain its biophysical mechanism, we first tested for XCFTR channel insertion into the plasma membrane by a substituted-cysteine-accessibility method. No insertion was detected during kinase stimulation. Next, we studied single-channel properties and found that the singlechannel open probability (P o) with PKA stimulation subsequent to PKC stimulation was 2.8-fold that observed in the absence of PKC preactivation and that single-channel conductance (␥) was increased by ϳ22%. To ascertain which XCFTR regions are responsible for the potentiation, we constructed several XCFTR-hCFTR chimeras, expressed them in Xenopus oocytes, and tested them electrophysiologically. Two chimeras [hCFTR NH 2-terminal region or regulatory (R) domain in XCFTR] showed a significant decrease in potentiation. In the chimera in which XCFTR nucleotide-binding domain (NBD)2 was replaced with the hCFTR sequence there was no potentiation whatsoever. The converse chimera (hCFTR with Xenopus NBD2) did not exhibit potentiation. These results indicate that potentiation by PKC involves a large increase in P o (with a small change in ␥) without CFTR channel insertion into the plasma membrane, that XCFTR NBD2 is necessary but not sufficient for the effect, and that the potentiation effect is likely to involve other CFTR domains. cystic fibrosis; chloride channel; protein kinases; ATP binding cassette proteins THE CYSTIC FIBROSIS transmembrane conductance regulator (CFTR) is a phosphorylation-and ATP hydrolysis-dependent Cl Ϫ channel (3, 21, 35, 36, 43) . Mutations of the CFTR gene cause cystic fibrosis, an inherited autosomal recessive disease more frequent in Caucasians (44). CFTR is expressed in the apical membrane of secretory epithelia and participates in Cl Ϫ and fluid secretion (17, 34). The CFTR molecule contains two repeated motifs; each consists of a membrane-spanning domain followed by a hydrophilic nucleotide-binding domain (NBD). Each membrane-spanning domain has six membrane-spanning helices. A highly charged cytoplasmic regulatory domain, the R domain, links the two halves of the molecule. R-domain phosphorylation by PKA facilitates ATP binding and hydrolysis in the NBDs, which by a complex mechanism causes channel gating (21, 35, 38) .
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The fact that R-domain phosphorylation is critical for the channel function of CFTR was documented by the following results: 1) CFTR is activated by PKA agonists in cells with native or heterologous expression (28, 36 -38, 41) ; 2) CFTR molecules lacking the R domain display Cl Ϫ channel function after exposure to phosphorylated R domain but not when exposed to unphosphorylated R domain (27, 46) ; 3) there are eight conserved PKA phosphorylation consensus sites in the R domain, and five of them have been shown to be phosphorylated in vivo and in vitro by PKA (12, 32) ; 4) phosphorylation changes the secondary structure of the R domain in vitro (19) ; 5) serine-to-alanine substitutions in the PKA phosphorylation consensus sites of the R domain greatly attenuate CFTR activation in response to PKA stimulation (4) .
In addition to its activation by PKA-mediated phosphorylation, CFTR could also be activated by other kinases such as PKC (9, 11, 15, 16, 23) , PKG (6, 20) , and calmodulin kinase (6, 32) . However, the molecular mechanism of the activation of CFTR by kinases other than PKA and the interaction between PKA and non-PKA kinases in the activation of CFTR are not fully understood. These issues are important to understand from the points of view of the regulation of CFTR-mediated Cl Ϫ transport by epithelial cells and the molecular mechanism of phosphorylation-mediated CFTR Cl Ϫ channel gating. Recently, we found that Xenopus laevis (X)CFTR exhibits a severalfold higher response to PKC activation than to PKA activation when expressed in Xenopus oocytes (7) . In the epithelial human (h)CFTR isoform, PKC stimulation potentiates the effect of PKA stimulation (40) . In the present study, we confirmed the effect of PKC on the activation of XCFTR by PKA stimulation and then tried to ascertain the biophysical and molecular mechanisms of this effect. We found that PKC potentiates the activation of XCFTR expressed in Xenopus oocytes by PKA stimulation, i.e., the response to PKA stimulation subsequent to PKC stimulation was eightfold greater than that without previous PKC stimulation. This effect was not present in oocytes expressing hCFTR. To identify the biophysical mechanism, we assessed changes of channel number (N), single-channel conductance (␥), and single channel open probability (P o ) of oocytes exposed to either PKA agonists or PKA and PKC agonists (potentiation). To identify the XCFTR regions responsible for the potentiation, we con-structed hCFTR-XCFTR chimeras and tested them electrophysiologically. To our surprise, the XCFTR NBD2, and not the R domain, appears to be critical for the potentiation effect.
MATERIALS AND METHODS
cDNA constructs and mutagenesis. hCFTR (a gift from Dr. LapChee Tsui, The Hospital for Sick Children, Toronto, ON, Canada), and XCFTR (a gift from Drs. Margaret Price and Michael Welsh, University of Iowa, Iowa City, IA) were cloned into pOcyt7 as previously described (7) . The mutations to generate R334C XCFTR and XCFTR-hCFTR chimeras (see Fig. 1 ) were introduced with the QuickChange Multi Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA), with all subcloning done through the plasmid pCR-4Blunt-TOPO with PCR-amplified CFTR DNA fragments. All sequences were directly confirmed by DNA sequencing at the Protein Chemistry Core Laboratory of the University of Texas Medical Branch. The mutagenic primer to generate the R334C mutant was 5Ј-GGCATT-TCACTCTGTAAGATCTTTACTACCATTTCATTTAGC-3Ј. A schematic representation of the chimeras studied is presented in Fig.  1 , and all amino acid positions are referred to the hCFTR sequence. Details about the construction of chimera B (hCFTR with residues Thr599 -Phe833 of XCFTR) have been published (7) . To generate chimera A (XCFTR with the Thr599 -Phe833 sequence of hCFTR), we introduced silent mutations into pOcyt7-XCFTR to add unique MluI and XbaI flanking sites in the sequence of interest with the primers 5Ј-GGCCAATAAAACGCGTATTTTAGTTACATCTAAAGTCG-AGC-3Ј (MluI) and 5Ј-GAAGATTTGAAGGAATGTTTTCTAGAT-GATACAGACAGCCC-3Ј (XbaI). The MluI/XbaI XCFTR sequence was then replaced with the corresponding hCFTR sequence obtained by PCR with primers containing MluI and XbaI flanking sites. The primer sequences were 5Ј-AATAAAACGCGTATTTTGGTCACT-TCTAAAATGGAAC-3Ј (MluI) and 5Ј-TATCATCTAGAAAGCA-CTCCTTTAAGTCTTCTTCG-3Ј (XbaI). To generate chimera C (XCFTR with Met1-Lys68 hCFTR sequence), we introduced a PacI restriction site (silent mutation) into the hCFTR DNA at the position coding for Lys68, using the mutagenic primer 5Ј-GGCTTCAAA-GAAAAATCCTAAATTAATTAATGCCCTTCGG-3Ј. The NH 2 terminus of XCFTR was then removed by XhoI/PacI digestion and replaced with the hCFTR DNA fragment cut with the same enzymes. A similar strategy was employed to construct chimeras E and H, where the sequences after transmembrane helix (TM)12 to the CFTR end were exchanged (Ser1149 -Leu1480). A unique NheI site was introduced into the hCFTR DNA (S1149A mutation) with the mutagenic primer 5Ј-TGCAGTGGGCTGTAAACGCTAGCATAGATGT-GGATAGC-3Ј. The XCFTR cDNA has a native NheI site at the corresponding position. The NheI/XhoI COOH-terminal fragments were then exchanged. To construct chimera D, BsiWI and MluI restriction sites flanking the fragment coding from TM5 to the NH 2 terminus of the R domain were introduced into the hCFTR and XCFTR DNAs (silent mutations). The mutagenic primers were 5Ј-GACTCGGAAGGCAGCGTACGTGAGATACTTCAATAGC-3Ј (hCFTR BsiWI), 5Ј-TACTCGAAAAGCTGCGTACGTGCGATAC-TTCAACAGCTC-3Ј (XCFTR BsiWI), and 5Ј-CTGATGGCTA-ACAAAACGCGTATTTTGGTCACTTC-3Ј (hCFTR MluI). The primer for the introduction of the MluI site in XCFTR was described above (see chimera A). To generate the chimeras in which NBD2 (chimera F, Ile1220 -Asp1425) or the sequence distal to NBD2 (chimera G, Asp1425-Leu1480) of XCFTR were replaced by the corresponding hCFTR sequences, we introduced XbaI and MluI sites flanking the NBD2 sequence of XCFTR with the primers 5Ј-CCTT-TCTGCAAATTATCTAGATGGAGGAAACAC-3Ј (XbaI, I1220L mutation), and 5Ј-GACAATACAGTACGACAGTACGCGTCTAT-TCAAAAGCTTGTG-3Ј (MluI, D1425A mutation). The XbaI/MluI NBD2 fragment of XCFTR was then replaced with the equivalent hCFTR sequence amplified by PCR, with XbaI/MluI flanking sites. A similar procedure was used to exchange the MluI/XhoI COOHterminal XCFTR fragment with the corresponding hCFTR sequence.
Oocyte preparation and cRNA injection. All animal procedures were conducted in accordance with the "Guiding Principles for Research Involving Animals and Human Beings" of the American Physiological Society. The protocol for preparing oocytes was described previously (7) . In brief, X. laevis ovarian lobes were surgically removed from anesthetized frogs and treated with 0.7 mg/ml type IV collagenase (Sigma-Aldrich) in Barth's solution (in mM: 88 NaCl, 1.0 KCl, 1.0 CaCl2, 1.0 MgCl2, and 10 HEPES-NaOH, pH 7.40) containing 10 mg/ml penicillin, 10 mg/ml streptomycin, and 100 mg/ml gentamicin sulfate for 16 h at 16°C. The enzymatic treatment was followed by incubation in calcium-free Barth's solution with gentle shaking for defolliculation, for 1 h. Defolliculated oocytes were incubated in Barth's solution for 2-4 h before injection. Oocytes were injected with 50 nl of CFTR cRNA (0.05-0.2 ng) or sterile water with a Nanoject autoinjector (Drummond Scientific, Broomall, PA). Typically, oocytes were used between 48 and 96 h after injection.
Dual-electrode voltage-clamp recordings. Oocytes were placed in an oocyte-recording chamber (model RC-2Z; Warner Instruments, Hamden, CT). Bathing solutions were changed by a gravity-driven perfusion system at a rate of ϳ 1 ml/min. Oocytes were bathed in the HEPES-buffered solution ND96 (in mM: 96.0 NaCl, 2.0 KCl, 1.0 MgCl2, 1.8 CaCl2, and 5.0 HEPES-NaOH, pH 7.5). All experiments were performed at room temperature (22-24°C) . Borosilicate microelectrodes were pulled with a horizontal puller (model P-98; Sutter Instruments, Novato, CA), were filled with 2.0 M KCl, and had tip resistances of 0.5-1.5 M⍀ when immersed in ND96 solution. A two-electrode voltage-clamp amplifier (model OC-725C; Warner In- NT, NH2-terminal region; MSD1 and MSD2, membrane-spanning domains that include 6 transmembrane helices and the corresponding intra-and extracellular loops; NBD1 and NBD2: first and second nucleotide-binding domains, respectively; R, regulatory domain; CT, COOH-terminal region distal to NBD2. struments) was used to amplify whole oocyte currents. Voltages were referenced to the bath. Oocytes were clamped at Ϫ40 mV. Membrane current and conductance were recorded using a setup described by Weber et al. (45) . In short, two digital signal processing (DSP) boards, which were equipped with two high-speed (200 kHz) analog-to-digital converters and two digital-to-analog converters, were connected to the two-electrode voltage-clamp amplifier via a multifunctional interface controlled by the DSP boards. The membrane conductance (Gm) was calculated from the membrane current and voltage change in response to a 1.0-Hz, 5-mV sine wave.
Single-channel recording. Single-channel recording protocols were adopted from Chan et al. (8) with some modifications. To remove the vitelline membrane, oocytes were shrunk for ϳ10 min in stripping solution containing (in mM) 250 K-aspartate, 20 KCl, 1 MgCl2, 10 HEPES, and 1 EGTA, pH 7.4 with KOH. The vitelline membranes were removed manually with fine tweezers, and the oocytes were transferred to a recording chamber containing ND96 solution. Patch pipettes were pulled from borosilicate glass with a horizontal puller (same as above), Sylgard coated, and fire polished to a resistance of 6 -10 M⍀ (pipettes filled with pipette solution and immersed in ND96 solution). The pipette solution contained (in mM) 128 N-methyl-D-glucamine chloride (NMG-Cl), 2 MgCl2, 5 HEPES, and 0.1 GdCl2, titrated to pH 7.4 with HCl; 150-to 200-G⍀ seals were obtained by gentle suction. The Ag-AgCl bath electrode was connected to the chamber bath by an agar bridge (2% agar in ND96). Outward unitary currents in CFTR channels were recorded at a pipette potential (Vp) of Ϫ40 mV, unless otherwise specified, via an Axopatch 200A amplifier (Axon Instruments, Union City, CA), filtered at 2 kHz with an eight-pole Bessel filter, and digitized online at 10 kHz with 100-Hz low pass by pCLAMP 8.2 (Axon Instruments).
The digitized, baseline-corrected currents from records containing one to five channels were idealized with the segmental K-means (SKM) algorithm (33) by Qub single-channel analysis software (State University of New York at Buffalo). Parameters of amplitude histograms and event occupancy were used to calculate ␥ and Po. Because of the outward rectification (5) in cell-attached patches, ␥ values were estimated from amplitude histograms of cell-attached records at holding potentials of 20 -100 mV. In excised patches the currents recorded at holding potentials of Ϫ80 to ϩ80 mV in symmetrical 140 mM Cl Ϫ concentration were plotted against the voltage, and straight lines were fitted to yield conductances. P o values were calculated using the equation (14):
where N is the number of channels in the patch and OS is the occupancy time fraction at each current level corresponding to S ϭ 1, 2, . . . , N. N was estimated from the maximum number of simultaneous openings in records 2-10 min long.
Drugs. To activate PKA, intracellular cAMP was elevated with a cAMP cocktail containing 250 M 8-bromoadenosine 3Ј,5Ј-cyclic monophosphate (8-BrcAMP) and 25 M forskolin (Sigma-Aldrich). To activate PKC, 250 nM phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich) was added to the bath. Stock solutions of these compounds were prepared in water (8-BrcAMP), dimethyl sulfoxide (PMA), or ethanol (forskolin) and diluted to the desired final concentration in ND96 solution immediately before use. [2-(Trimethylammonium)ethyl]methanethiosulfonate bromide (MTSET ϩ ) was dissolved in bath solution to a 1 mM concentration immediately before use from a 1 M stock in water stored in Ϫ20°C. ␤-Mercaptoethanol (␤-ME) was dissolved in bath solution to a final 2 mM concentration immediately before use. At the concentrations used, the vehicles had no effects on the CFTR currents (not shown).
Statistical analysis. Data are expressed as means Ϯ SE. Differences between means were compared by paired or unpaired twotailed t-tests, as appropriate. Statistical significance was ascribed to P Ͻ 0.05.
RESULTS
Response of CFTR to PKA and PKC stimulation. The changes in conductance elicited by stimulation of PKA or PKC are illustrated in Fig. 2 . We have observed that the response to PKC stimulation is much larger than that to PKA stimulation in XCFTR (Y. Chen et al., unpublished observations), and the biophysical and molecular mechanisms of this response have been addressed elsewhere (7, 13) .
The relative responses to PKA and PKC stimulation in the same oocyte were dependent on the sequence of administration of the kinase agonists. As depicted in Fig. 3 , consecutive stimulations of PKA yield similar changes in XCFTR conductance (Fig. 3A) . In contrast, after a transient exposure to a PKC agonist (Fig. 3B) , the conductance increase elicited by the second PKA stimulation in XCFTR was 8.7 Ϯ 0.8 (n ϭ 8) times the first stimulation. The same experiment in hCFTR (Fig. 3C) yielded no difference between the effects of PKA agonists: the second change in conductance was 0.89 Ϯ 0.08 (n ϭ 6) relative to the first change (Fig. 3D) . This study is focused on the large difference between the effects of PKC stimulation on the responses of hCFTR and XCFTR to the consecutive exposure to cAMP, as summarized in Fig. 3D .
Potentiation effect does not involve new channel insertion into plasma membrane. In principle, the increase in CFTR conductance that characterizes the potentiation effect could result from increases in N, P o , and/or ␥. First, we addressed the possibility that exocytic insertion of new channels from an intracellular pool is responsible, solely or in part, for the potentiation effect in XCFTR. To this end, we used the substituted-cysteine-accessibility method (1, 2, 24 ). Arg334, a position thought to be in the extracellular mouth of the CFTR channel and accessible from the extracellular side, was mutated to Cys. Charged, membrane-impermeable thiol reagents react at this site and change the conductance of the CFTR channels (1, 24) . In control experiments, the increase in G m elicited by the thiol reagent MTSET ϩ (1 mM) was 98 Ϯ 5% (n ϭ 6) in activated XCFTR-R334C (Fig. 4, A and B) . The effect of MTSET ϩ was persistent but could be fully reversed by the reducing agent ␤-ME. MTSET ϩ had no effect on wild-type CFTR (data not shown). To test for channel insertion, oocytes expressing XCFTR-R334C were exposed to MTSET ϩ for 10 -20 s during the first PKA stimulation and then the agent was washed out from the bath. The oocyte was then stimulated by PKC and PKA sequentially and reexposed to MTSET ϩ when the conductance change reached a plateau after the second PKA stimulation (Fig. 4, A and B) . Under these conditions, any new channels inserted in the membrane by the action of the kinases would be responsive to the second exposure to MTSET ϩ , whereas the preexisting channels would not, because they remain labeled by the preexposure to the MTSET ϩ . As illustrated in Fig. 4C , when oocytes expressing XCFTR-R334C were stimulated by PKA subsequent to PKA and PKC stimulation, there was no appreciable change in conductance with the second exposure to MTSET ϩ . These results, summarized in Fig. 4D , rule out a measurable role of a change in N as an explanation for the PKC potentiation effect on PKA activation of XCFTR.
Increase in P o is main mechanism of G m increase by PKC potentiation. To investigate the possible roles of single-channel P o or ␥ on the macroscopic CFTR conductance elicited by the potentiation effect, we used the cell-attached patch-clamp technique. Detailed single XCFTR channel properties in the cellattached configuration in Xenopus oocytes are described by us elsewhere (13) . The gating pattern (Fig. 5A) of XCFTR expressed in Xenopus oocytes resembled that observed in cells with endogenous expression (39) . Single-channel slope conductance after PKA stimulation was 7.7 Ϯ 0.5 pS, and P o was 0.05 Ϯ 0.02 (13) . After PKC stimulation, PKA stimulation elicited openings with a ␥ of 9.4 Ϯ 0.4 pS (n ϭ 5; Fig. 5B ) and a P o of 0.14 Ϯ 0.03 (n ϭ 6; Fig. 5C ). Both differences were statistically significant; ␥ at the P Ͻ 0.025 level and P o at the P Ͻ 0.001 level, indicating that both P o and ␥ during PKA stimulation are increased by preexposure to PKC agonists. The magnitudes of the changes are very different, however. To- gether, the average increases (␥ by 22% and P o by 180%) should yield an increase in G m by ϳ3.5-fold, most of which is attributable to the increase in P o (see DISCUSSION) .
NBD2 of XCFTR is necessary, but not sufficient, for potentiation effect. The fact that potentiation is observed in XCFTR, but not in hCFTR, both expressed in the same system, suggests that differences between these CFTR orthologs, independently of the expression system, account for the different response to kinase stimulation. We tried to identify the regions involved in the potentiation effect by constructing and testing a series of hCFTR-XCFTR chimeras (Fig. 1) . The results are illustrated in Fig. 6 and summarized in Fig. 7 .
The R domain is the phosphorylation domain critical for the activation of the CFTR channel by either PKA or PKC (21, 38 ). Thus we first tested whether the differences between the R domains of XCFTR and hCFTR are responsible for the fact that the potentiation effect exists in XCFTR but not in hCFTR. We constructed chimeras in which the R domains of hCFTR and XCFTR were exchanged. The conductance elicited by PKA stimulation after exposure to PKC agonist (relative to stimulation of PKA without preexposure) was 4.2 Ϯ 0.5 in chimera A (XCFTR with hCFTR R-domain sequence; P Ͻ 0.01, n ϭ 10), as illustrated in Fig. 6A and summarized in Fig. 7 . Although the response of this chimera to PKA stimulation after PKC stimulation was smaller than that of XCFTR, the phenomenon was still present. Chimera B (hCFTR with XCFTR R-domain sequence) did not display potentiation (Fig. 7) . The potentiation effect persisted in the chimeras in which the NH 2 -terminal region (chimera C) or the TM5-NBD1 sequence (chimera D) of XCFTR was replaced by the corresponding sequence from hCFTR (Fig. 7) . These results indicate that differences in the sequences of the XCFTR and hCFTR TM5-NBD1 do not explain the potentiation effect and that sequences in the R domain and the NH 2 -terminal domain are not necessary for, but significantly decrease the magnitude of, the potentiation effect.
In contrast with the above results, replacing the COOHterminal region of XCFTR with the corresponding sequences from hCFTR in chimera E eliminated the PKC potentiation effect (Fig. 7) , i.e., the conductance response to PKA agonists after PKC stimulation was the same as that before PKC stimulation. To narrow down the responsible region, we studied chimeras in which only the NBD2 (chimera F) or the COOH-terminal region distal to NBD2 (chimera G) was replaced with the corresponding sequence from hCFTR, respectively. In chimera F (Figs. 6B and 7 ) the potentiation disappeared, whereas in chimera G the potentiation (ratio of conductances with PKA activation after and before PKC stimulation ϭ 4.7 Ϯ 1.3; n ϭ 4) persisted (Fig. 7) . These results indicate that the NBD2 sequence is necessary for the kinase potentiation effect of XCFTR. To explore whether the COOH-terminal XCFTR sequence including NBD2 and the COOH-terminal region is sufficient to confer the PKC potentiation effect, we constructed a chimera (H) in which this XCFTR sequence replaced the corresponding hCFTR sequence. This chimera did not display the PKC potentiation effect (Fig. 7) . These results indicate that NBD2 is necessary, but not sufficient, for the PKC potentiation effect observed in the XCFTR. Together, these results suggest that the molecular bases for the potentiation effect in XCFTR are complex (see DISCUSSION) . (1 mM) were tested twice: during exposure to cAMP cocktail and then during a second exposure to cAMP cocktail after a transient period with PMA. B: expanded record of the first exposure to cAMP and MTSET in A shows a rapid, significant increase in Gm. C: expanded record of the second exposure to cAMP and MTSET (after PMA) in A shows that Gm is virtually unchanged. D: summary of MTSET ϩ modification effect (⌬Gm) normalized to the conductance before MTSET (Gm) (n ϭ 6). The first MTSET exposure elicits a large change in Gm (0.98 Ϯ 0.10), whereas the second exposure has a much smaller effect (0.05 Ϯ 0.02). The difference (paired analysis) was significant at P Ͻ 0.01.
DISCUSSION
The central result in this study is that in XCFTR the activation of PKA subsequent to PKC stimulation elicits a response larger than that to PKA stimulation without pretreatment with PKC agonist. The PKC potentiation effect studied here is not observed in hCFTR when both CFTR orthologs are expressed in Xenopus oocytes, suggesting that this phenomenon is CFTR molecule specific, but at present we cannot rule out the possibility that the potentiation effect involves one or more factors of the host cell in addition to the CFTR molecule. In other words, the Xenopus oocyte may express a protein that is involved in the PKC potentiation effect and interacts with XCFTR but not with hCFTR. In addition, to our knowledge, this effect has not been investigated in cells with native expression of XCFTR.
The PKC potentiation in XCFTR is different from the PKC activation (7) and the PKC permissive effect (Ref. 23 and below). Our previous results (7) demonstrated that PKC activation in XCFTR depends on a single PKC phosphorylation consensus site (T 665 LRR) in the R domain. A PKC consensus site at this location exists in CFTR from all species so far sequenced (from dogfish to chimpanzee) except human and zebra fish (TLHR). We found that the activation by PKC stimulation was abolished in the mutant T665A XCFTR and transferred to the hCFTR mutant TLHR 3 TLRR (7). The chimera in which the XCFTR R domain was replaced with the corresponding hCFTR sequence (chimera B) lacks the PKC activation site; nevertheless, it exhibits potentiation, indicating that these two processes have different molecular bases. A third phenomenon is the requirement for a certain basal level of PKC activity for the activation of CFTR by PKA stimulation, named the PKC permissive effect by Hanrahan's group (23) . This effect, present in both XCFTR and hCFTR, depends on several PKC phosphorylation consensus sites in the R domain and NBD1 (10, 13) . Hence, the three modes by which PKC stimulation affects CFTR function can be distinguished because of the ortholog specificity (hCFTR vs. XCFTR) or because of the different amino acid residues involved.
Concerning the biophysical mechanism of potentiation, we tested whether the insertion of new channels plays a role. Channel insertion has been assessed from changes in plasma membrane electrical capacitance in parallel with increases in conductance, which are interpreted to result from vesicle fusion (26, 42, 45) . A problem with this method is that accurate measurements of membrane capacitance are difficult, in particular when G m is changing, as is the case with the stimulation of CFTR by kinase agonists (12) . In addition, the possibility exists that the membrane vesicles fusing with the membrane do not contain the channels. In our hands, there were no consistent correlations between the apparent capacitance and conductance changes during kinase stimulation (data not shown). Membrane protein labeling and detection by immunofluorescence or Western blot analysis has also been used to address this question. A problem with this approach is that the labeling process is slow, taking tens of minutes to hours, and therefore makes it difficult to assess acute effects of kinase stimulation. In addition, this methodology does not allow for identification of functional copies of the protein under study. For these reasons, we used the substituted-cysteine-accessibility method (1, 2, 24) to assess whether or not the potentiation phenomenon involves CFTR channel insertion. The results with the substituted-cysteine-accessibility method indicate that insertion of new channels does not play a significant role in the potentiation effect. These results extend the observations of Dawson's group (24) , who showed a lack of insertion of new channels when hCFTR-expressing oocytes were treated with PKA agonists. Confirming their observations, we also obtained a negative result with PKA stimulation (data not shown). We conclude that the proposal of channel insertion based on increases in membrane capacitance observed when oocytes expressing hCFTR are exposed to PKA agonists (24, 42, 45) is incorrect. Either the assessment of the capacitance is in error (12) or vesicles fuse with the plasma membrane but do not contain activatable CFTR molecules. An important point is that exocytic insertion of CFTR channels may vary among cell types and/or among orthologs (25) . Thus the results of Dawson's group and ours, obtained in Xenopus oocytes, cannot be generalized to other systems.
Both single-channel ␥ and P o are increased in response to PKA stimulation after PKC stimulation. The change in P o was quite large, indicating that this is the main mechanism of increase of macroscopic conductance; the change in ␥ was small, but significant, and we also observed it after stimulation of XCFTR with PKC agonist alone (13) . There was a significant difference between the relative changes in whole cell conductance and single-channel properties. However, these numbers may not be directly comparable because of the faster superfusion of the oocytes in the whole cell experiments and difficulties in determining the time of maximal stimulation of on-cell CFTR channels. Regulation of ion channels by PKCmediated phosphorylation is not generally expected to involve changes in single-channel ␥, but it has been observed in a few instances (18, 29, 30) .
The R-domain sequence differences between XCFTR and hCFTR are not responsible for the lack of kinase potentiation effect in hCFTR. This is a surprising result, given the dominant role of the R domain in the regulation of CFTR by phosphorylation (9, 31, 32) . Interestingly, Chang et al. (9) noted that hCFTR could still be activated by PKA stimulation in a mutant in which all PKA consensus phosphorylation sites were knocked out in the R domain. Also, both hCFTR and XCFTR could be partially activated by PKA or PKC stimulation when Ser/Thr residues in all PKC phosphorylation consensus sites in the R domain were mutated to Ala (13) . Possible explanations for these results are phosphorylation of cryptic sites outside the R domain, indirect phosphorylation of CFTR by another kinase activated by PKA or PKC, or a protein kinase-sensitive accessory protein that would interact with CFTR. All these possibilities could in principle apply to the kinase potentiation effect on XCFTR.
Even if the effect of kinase stimulation on CFTR requires phosphorylation of one or more unknown accessory proteins, the accessory protein(s) must interact with CFTR molecules to change CFTR channel function. Thus the different PKC potentiation effects in hCFTR and XCFTR must stem from the difference in the structure of these two CFTR homologs. Elimination of the PKC potentiation effect of XCFTR in chimeras in which NBD2 was replaced by the corresponding hCFTR sequences indicates that the difference between the NBD2s of XCFTR and hCFTR is critical for the PKC potentiation effect observed in XCFTR. The fact that replacement of the hCFTR sequence beyond the beginning of NBD2 with the corresponding XCFTR sequence did not confer the PKC potentiation effect indicates that the NBD2 difference is not sufficient for this effect. It is possible that other domains are involved; these domains would have a positive effect in XCFTR and/or a negative effect in hCFTR, always in association with XCFTR NBD2. The significant decrease of the potentiation effect in chimeras A and C (compared with XCFTR) suggests that the R domain and the NH 2 -terminal domain may also be involved. In contrast, the differences of the NBD1s, TM5 and 6, and the COOH-terminal region of XCFTR are not necessary for the PKC potentiation effect. Additional experiments will be required to identify the specific sequence in NBD2 that is responsible for the PKC potentiation effect and the roles of other CFTR domains.
The molecular basis for the critical role of NBD2 in mediating the PKC potentiation effect remains unknown. One possibility is a difference in NBD2 phosphorylation between XCFTR and hCFTR. There are five PKA or PKC phosphorylation consensus sites in XCFTR NBD2 (2 of them are also present in hCFTR), but there is currently no evidence for phosphorylation of these sites. In contrast, the critical sites for ATP binding and hydrolysis in NBD2 are conserved in these two molecules. Another possibility is phosphorylation of accessory protein(s) that may interact with NBD2. Alreadyknown CFTR accessory proteins such as CAP70 and syntaxin 1A are unlikely candidates because they do not interact with the NBD2 of hCFTR (22, 44) .
In summary, we found that the response to PKA stimulation increases severalfold by preexposure of XCFTR to PKC agonist. The biophysical bases for the potentiated macroscopic response to PKA stimulation are a large increase in singlechannel P o and a modest increase in single-channel ␥ with no detectable change in number of channels in the plasma membrane. The differences between the NBD2s of hCFTR and XCFTR are critical for the XCFTR-specific PKC potentiation effect, and the NH 2 -terminal domain and R domain are not essential but may participate in the effect. Future efforts to dissect the molecular mechanism of the potentiation effect may help our understanding of the regulation of CFTR by phosphorylation.
